When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FLGT - Fulgent's COVID-19 Tests Are Ramping Fast But Their Other Tests Are Suffering
Fulgent Genetics Inc.
Fulgent Genetics (FLGT) has rapidly developed a couple of tests for COVID-19, which is at least in part substituting the pandemic-related decline in its core business, but we think the latter is temporary, as were the incurred costs for developing the COVID-19 tests.
As demand for the company's COVID-19 tests are ramping rapidly and their core business is coming back, we think the shares are still attractive.
We bought Fulgent Genetics at $9.87 for the SHU portfolio last November, and it has been quite a ride:
The company was growing very substantially, and in Q1